Moreover, SIGLEC8, the human counterpart of Siglec-F, was upregulated in renal tissues from patients with diabetic nephropathy or FSGS compared with healthy controls as well as in fibrotic renal tumor tissues from patients compared with their healthy renal tissues. The gene discussed is SIGLEC8; the disease is focal segmental glomerulosclerosis.